143 results on '"Yoshimatsu Kentaro"'
Search Results
2. Lyn Kinase Suppresses the Transcriptional Activity of IRF5 in the TLR-MyD88 Pathway to Restrain the Development of Autoimmunity
3. Supplemental Materials and Methods from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
4. Supplemental Figure 2 from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
5. Supplemental Figure Legends from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
6. Supplemental Figure 3 from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
7. Supplemental Table 1 from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
8. Data from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
9. Supplemental Figure 4 from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
10. Supplemental Figure 1 from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
11. Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatment
12. α6β1 integrin induces proteasome-mediated cleavage of erbB2 in breast cancer cells
13. Stem Cell Factor/c-kit Signaling Promotes the Survival, Migration, and Capillary Tube Formation of Human Umbilical Vein Endothelial Cells
14. Medicinal genetics approach towards identifying the molecular target of a novel inhibitor of fungal cell wall assembly
15. Abstract 1299: Potential antitumor effects of a Golgi disrupting agent, M-COPA,viatargeting cell-extracellular matrix interaction under the spheroid culture conditions
16. Schizosaccharomyces pombe och1+ encodes α-1,6-mannosyltransferase that is involved in outer chain elongation of N-linked oligosaccharides
17. Endogenous AP-1 Levels Necessary for Oncogenic Activity Are Higher Than Those Sufficient to Support Normal Growth
18. Targeting the Golgi apparatus to overcome acquired resistance of non-small cell lung cancer cells to EGFR tyrosine kinase inhibitors
19. M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
20. A critical link between Lyn-mediated suppression of the TLR-MyD88-IRF5 pathway and the development of SLE-like disease
21. Erratum to “Report of the international conference on regulatory endeavors towards the sound development of human cell therapy products” [Biologicals 43 (5) (2015) 283–297]
22. Report of the international conference on regulatory endeavors towards the sound development of human cell therapy products
23. Purification and cDNA cloning of a novel factor produced by a human T-cell hybridoma: Sequence homology with animal lectins
24. Synthesis and evaluation of novel antifungal agents-quinoline and pyridine amide derivatives
25. Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage
26. In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds
27. Efficacy of Oral E1210, a New Broad-Spectrum Antifungal with a Novel Mechanism of Action, in Murine Models of Candidiasis, Aspergillosis, and Fusariosis
28. Pladienolides, New Substances from Culture of Streptomyces platensis Mer‐11107. Part 3. In vitro and in vivo Antitumor Activities.
29. An Angiogenesis Inhibitor E7820 Shows Broad-Spectrum Tumor Growth Inhibition in a Xenograft Model
30. Synthesis and Evaluation of Novel Pyrimido-Acridone, -Phenoxadine, and -Carbazole as Topoisomerase II Inhibitors
31. Pladienolides, New Substances from Culture of Streptomyces platensis Mer-11107 III. In Vitro and In Vivo Antitumor Activities
32. A novel carbazole topoisomerase II poison, ER‐37328: potent tumoricidal activity against human solid tumors in vitro and in vivo
33. ChemInform Abstract: Synthesis and Biological Evaluation of N‐(7‐Indolyl)‐3‐pyridinesulfonamide Derivatives as Potent Antitumor Agents.
34. Aberrant expression of integrin and erbB subunits in breast cancer cell lines
35. Array-Based Structure and Gene Expression Relationship Study of Antitumor Sulfonamides IncludingN-[2-[(4-Hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide andN-(3-Chloro-7-indolyl)-1,4-benzenedisulfonamide
36. Synthesis and biological evaluation of N-(7-indolyl)-3-pyridinesulfonamide derivatives as potent antitumor agents
37. Anticancer Agent E7070 Inhibits Amino Acid and Uracil Transport in Fission Yeast
38. Cell Cycle Regulation in the G1 Phase: A Promising Target for the Development of New Chemotherapeutic Anticancer Agents
39. ChemInform Abstract: Luminacins: A Family of Capillary Tube Formation Inhibitors from Streptomyces sp. Part 2. Biological Activities.
40. Schizosaccharomyces pombe och1+encodes α-1,6-mannosyltransferase that is involved in outer chain elongation ofN-linked oligosaccharides
41. ChemInform Abstract: A Focused Compound Library of Novel N‐(7‐Indolyl)benzenesulfonamides for the Discovery of Potent Cell Cycle Inhibitors.
42. A focused compound library of novel N -(7-indolyl)benzenesulfonamides for the discovery of potent cell cycle inhibitors
43. Luminacins. A Family of Capillary Tube Formation Inhibitors from Streptomyces sp. II. Biological Activities.
44. Discovery of Novel Antitumor Sulfonamides Targeting G1 Phase of the Cell Cycle
45. Rapid development of hepatic metastasis with high incidence following orthotopic transplantation of murine colon 38 carcinoma as intact tissue in syngeneic C57BL/6 mice
46. Preferential Binding of E7010 to Murine β3-Tubulin and Decreased β3-Tubulin in E7010-resistant Cell Lines
47. Two Proteins Translated by Alternative Usage of Initiation Codons in mRNA Encoding a JunD Transcriptional Regulator
48. Novel 6-5 Fused Ring Heterocycle Antifolates with Potent Antitumor Activity: Bridge Modifications and Heterocyclic Benzoyl Isosters of 2,4-Diamino-6,7-dihydro-5H-cyclopenta(d)pyrimidine Antifolate.
49. Synthesis and Antitumor Activities of Novel 6-5 Fused Ring Heterocycle Antifolates: N-[4-[.omega.-(2-Amino-4-substituted-6,7-dihydrocyclopenta[d]pyrimidin-5-yl)alkyl]benzoyl]-L-glutamic Acids
50. Serum levels of major basic protein in patients with or without eosinophilia: measurement by enzyme-linked immunosorbent assay
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.